Correlation Between INmune Bio and Adagene
Can any of the company-specific risk be diversified away by investing in both INmune Bio and Adagene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining INmune Bio and Adagene into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between INmune Bio and Adagene, you can compare the effects of market volatilities on INmune Bio and Adagene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in INmune Bio with a short position of Adagene. Check out your portfolio center. Please also check ongoing floating volatility patterns of INmune Bio and Adagene.
Diversification Opportunities for INmune Bio and Adagene
-0.3 | Correlation Coefficient |
Very good diversification
The 3 months correlation between INmune and Adagene is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding INmune Bio and Adagene in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Adagene and INmune Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on INmune Bio are associated (or correlated) with Adagene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Adagene has no effect on the direction of INmune Bio i.e., INmune Bio and Adagene go up and down completely randomly.
Pair Corralation between INmune Bio and Adagene
Given the investment horizon of 90 days INmune Bio is expected to generate 1.93 times more return on investment than Adagene. However, INmune Bio is 1.93 times more volatile than Adagene. It trades about 0.15 of its potential returns per unit of risk. Adagene is currently generating about -0.1 per unit of risk. If you would invest 465.00 in INmune Bio on December 29, 2024 and sell it today you would earn a total of 287.00 from holding INmune Bio or generate 61.72% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
INmune Bio vs. Adagene
Performance |
Timeline |
INmune Bio |
Adagene |
INmune Bio and Adagene Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with INmune Bio and Adagene
The main advantage of trading using opposite INmune Bio and Adagene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if INmune Bio position performs unexpectedly, Adagene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adagene will offset losses from the drop in Adagene's long position.INmune Bio vs. Anebulo Pharmaceuticals | INmune Bio vs. AN2 Therapeutics | INmune Bio vs. Cue Biopharma | INmune Bio vs. Anixa Biosciences |
Adagene vs. Aerovate Therapeutics | Adagene vs. Acrivon Therapeutics, Common | Adagene vs. Rezolute | Adagene vs. AN2 Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |